Literature DB >> 24692172

High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis.

Shoji Ichikawa1, Amie K Gray, Leah R Padgett, Austin M Reilly, Tyler R Unsicker.   

Abstract

Familial tumoral calcinosis is characterized by ectopic calcifications due to persistent hyperphosphatemia. The most common genetic cause of the disease is mutations in GALNT3, encoding a glycosyltransferase involved in a posttranslational modification of fibroblast growth factor 23 (FGF23). The Galnt3 knockout mouse we developed was hyperphosphatemic due to low intact Fgf23 levels, but did not develop any apparent calcifications on a standard rodent diet. We therefore tested the hypothesis that a further challenge with a high phosphate diet could induce ectopic calcifications in Galnt3 knockout mice. Mice were fed either normal (0.6%) or high (1.65%) phosphate diet for 20 weeks beginning from weaning at 3 weeks. The high phosphate diet did not affect serum phosphorus concentration. However, regardless of the dietary phosphate contents, serum phosphorus levels were consistently elevated in Galnt3 knockout mice. The mice on the high phosphate diet had slightly low serum calcium, but significantly high alkaline phosphatase, parathyroid hormone (PTH), and calcium in the kidney. Although none of Galnt3 knockout mice on the normal phosphate diet developed calcifications, calcifications appeared in approximately one-half of the mice on the high phosphate diet by 12 weeks. Calcified masses were most often found around the neck and on the back and as large as 9.9 mm in length. These data indicate that dietary phosphate load has major impact on the development of ectopic calcifications in tumoral calcinosis.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ECTOPIC CALCIFICATION; FGF23; GALNT3 KNOCKOUT MICE; HYPERPHOSPHATEMIA; TUMORAL CALCINOSIS

Mesh:

Substances:

Year:  2014        PMID: 24692172     DOI: 10.1002/jbmr.2242

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?

Authors:  Debora Claramunt-Taberner; Aurélia Bertholet-Thomas; Marie-Christine Carlier; Frédérique Dijoud; Franck Chotel; Caroline Silve; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2018-03-28       Impact factor: 3.714

Review 2.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Bonekey Rep       Date:  2015-06-03

3.  Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.

Authors:  Erica L Clinkenbeard; Taryn A Cass; Pu Ni; Julia M Hum; Teresita Bellido; Matthew R Allen; Kenneth E White
Journal:  J Bone Miner Res       Date:  2016-03-04       Impact factor: 6.741

4.  Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.

Authors:  Austin M Reilly; Amie K Gray; Sharon M Moe; Shoji Ichikawa
Journal:  Bone       Date:  2014-07-04       Impact factor: 4.398

5.  Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.

Authors:  Shoko Nakamura; Masayuki Horie; Tomo Daidoji; Tomoyuki Honda; Mayo Yasugi; Atsushi Kuno; Toshihisa Komori; Daisuke Okuzaki; Hisashi Narimatsu; Takaaki Nakaya; Keizo Tomonaga
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

Review 6.  Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management.

Authors:  Alison M Boyce; Alisa E Lee; Kelly L Roszko; Rachel I Gafni
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-08       Impact factor: 5.555

7.  High phosphate diet suppresses lipogenesis in white adipose tissue.

Authors:  Yukiko Imi; Norie Yabiki; Maerjianghan Abuduli; Masashi Masuda; Hisami Yamanaka-Okumura; Yutaka Taketani
Journal:  J Clin Biochem Nutr       Date:  2018-07-11       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.